Skip Navigation



International Immunology Advance Access published online on January 7, 2008

International Immunology, doi:10.1093/intimm/dxm140
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/2/277    most recent
dxm140v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kitao, H.
Right arrow Articles by Takata, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitao, H.
Right arrow Articles by Takata, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Japanese Society for Immunology. 2008. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Regulation of histone H4 acetylation by transcription factor E2A in Ig gene conversion

Hiroyuki Kitao1,*, Masayo Kimura2,6,*, Kazuhiko Yamamoto2, Hidetaka Seo3, Keiko Namikoshi2, Yasutoshi Agata4, Kunihiro Ohta5 and Minoru Takata1

1 Department of Late Effect Studies, Radiation Biology Center, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan
2 Department of Immunology and Molecular Genetics, Kawasaki Medical School, Okayama 701-0192, Japan
3 Chiome Bioscience Inc., Tokyo 113-0033, Japan
4 Department of Developmental Infectious Diseases, Research Institute, Osaka Medical Center for Maternal and Child Health, Izumi-shi, Osaka 594-1101, Japan
5 Department of Life Sciences, Graduate School of Arts and Sciences, University of Tokyo, Tokyo 153-8902, Japan
6 Present address: Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-5885, Japan

Correspondence to: Correspondence to: M. Takata; E-mail: mtakata{at}house.rbc.kyoto-u.ac.jp

Recent studies implicate the transcription factor E2A in Ig diversification such as somatic hypermutation or gene conversion (GCV). GCV also requires active Ig transcription, expression of the activation-induced deaminase (AID) and a set of homologous recombination factors. We have disrupted the E2A gene in the chicken B-cell line DT40 and found greatly diminished rate of GCV without changes in the levels of transcripts from AID and Ig heavy chain or Ig light chain (IgL) genes. However, chromatin immunoprecipitation analysis revealed that the loss of E2A accompanies drastically reduced acetylation levels of the histone H4 in rearranged IgL locus. Furthermore, the defects in GCV were restored by trichostatin A treatment, which raised H4 acetylation to the normal levels. Thus, E2A may contribute to GCV by maintaining histone acetylation, which could be a prerequisite for targeting or full deaminase function of AID.

Keywords: activation-induced deaminase, chromatin immunoprecipitation, DT40 cell line


* These authors contributed equally to this study.

Transmitting editor: T. Kurosaki

Received 5 September 2007, accepted 30 November 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.